Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial

Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial

OBJECTIVE To investigate whether vitamin D and marine derived long chain omega 3 fatty acids reduce autoimmune disease risk. DESIGN Vitamin D and omega 3 trial (VITAL), a nationwide, randomized, double blind, placebo controlled trial with a two-by-two factorial design. SETTING Nationwide in the Unit...

Full description

Bibliographic Details
Main Authors: Alexander, E.K (Author), Bubes, V. (Author), Cook, N.R (Author), Costenbader, K.H (Author), Friedman, S. (Author), Hahn, J. (Author), Kotler, G. (Author), Lee, I.-M (Author), Manson, J.E (Author), Walter, J. (Author)
Format: Article
Language:English
Published: BMJ Publishing Group 2022
Subjects:
adult
aged
Aged
Article
autoimmune disease
Autoimmune Diseases
autoimmune thyroiditis
Cholecalciferol
clinical trial
colecalciferol
controlled study
dietary supplement
Dietary Supplements
double blind procedure
Double-Blind Method
Fatty Acids, Omega-3
female
Female
follow up
Follow-Up Studies
human
Humans
incidence
Incidence
major clinical study
male
Male
middle aged
Middle Aged
omega 3 fatty acid
phase 3 clinical trial
placebo
prospective study
psoriasis
randomized controlled trial
rheumatic polymyalgia
rheumatoid arthritis
supplementation
treatment outcome
Treatment Outcome
United States
vitamin D
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items